Clinical TrialsSearch results
Number of results: 510
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A Study on Skin Incision Designs in THA
- Osteoarthritis of the hip Rheumatoid arthritis Osteonecrosis of the femoral head Femoral fracture
- Tetsunaga Tomonori
- 2024-10-09
Recruiting
- Phase II study of Revival of Platinum-doublet Chemotherapy in Advanced NSCLC patients Resistant to Combination Immunotherapy
- Non-small cell lung cancer
- Ninomiya Kiichiro
- 2024-10-08
Not yet recruiting
- A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- Relapsed Refractory Multiple Myeloma
- Rafael Conti, MD
- 2024-09-18
Recruiting
- Characteristics of Long-term Survivors to Tremelimumab plus Durvalumab Therapy for HCC
- Hepatocellular Carcinoma
- OTSUKA MOTOYKI
- 2024-09-17
Recruiting
- Impact of Electrical Stimulation Therapy on Post-Extubation Dysphagia during Mechanical Ventilation
- Post extubation dysphagia
- Hongo Takashi
- 2024-09-13
Recruiting
- A study of aminolevulinic acid phosphate as an aid to functional recovery in patients with sarcopenia
- Sarcopenia
- Sugimoto Ken
- 2024-09-13
No Longer Recruiting
- The investigation of the therapeutic effects of two types of traditional Chinese medicine on COVID-19 sequelae.
- post-COVID-19 syndrome (generalized fatigue)
- UEDA KEIGO
- 2024-09-11
Recruiting
- Efficacy of phosphorylated pullulan in endoscopic therapy for early gastric cancer
- Early gastric cancer
- Otsuka Motoyuki
- 2024-09-11
Recruiting
- Preoperative Immuno-Nutritional Therapy for Lung Cancer
- lung cancer
- Shien Kazuhiko
- 2024-09-02
Recruiting
- A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer (Krascendo1)
- 2L+ NSCLC with KRAS G12C positive
- Venice Archer
- 2024-08-19